The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- Comprehensive Guide to Dental Splints in Neuromuscular Dentistry (NMD)
- GLP-1 Receptor Agonists and Oral Health: Essential Insights for Dentists
- “Why Saliva pH Testing Should Be Mandatory in Dentistry: Prevent Diet-Induced Cavities”
- DIM: A Breakthrough Natural Compound for Preventing Tooth Decay
- Neuromuscular Dentistry & Myocentric Mandate: Boosting Systemic Health Beyond Occlusion
Archives